Skip to content

Yoga for Smoking and Tobacco Cessation

Yoga as a complementary intervention for Tobacco Cessation: A PROBE Trial - QUIT-SMART

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/01/022692
Enrollment
200
Registered
2020-01-10
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F172- Nicotine dependence

Interventions

Intervention1: Yoga Group: Yoga intervention will be performed at the Centre for Integrative Medicine and Research (CIMR) at AIIMS, New Delhi. Along with the standard medical therapy, participants wil

Sponsors

Centre for Integrative Medicine and Research CIMR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a. smoking rate of at least 5 cigarettes/day for at the least the past year, b. between the ages of 18 and 45 years (according to the 7th edition of the American College of Sports Medicine (ACSM)ââ?¬•s guidelines for exercise testing and prescription, males c. normal (or corrected-to-normal) hearing and vision, d. willing and able to participate in 40 min of moderately intense exercise or yoga, e. no contradictions for moderate-intensity exercise based on the Physical Activity Readiness Questionnaire(Thomas, Reading, & Shephard, 1992), f. body mass index of less than 35 g. not currently practicing regular or structured yoga program.

Exclusion criteria

Exclusion criteria: a. physically active participants ( > 3 days of moderate-intensity physical activity or > 2 days of vigorous intensity physical activity per week), b. practicing yoga before recruitment in the current trial, c. were currently enrolled in a quit-smoking program, d. had a medical condition that might make participation in yoga difficult or potentially hazardous (e.g., heart failure, ischemia, hypertension, diabetes) e. other substance use such as cannabis, alcohol or opioid dependency f. taking any benzodiazepines, antidepressants, neuroleptics, stimulants, anticonvulsants, or beta agonists,

Design outcomes

Primary

MeasureTime frame
I. Salivary cotinine II. Carbon monoxide levels in breath III. Fagerstrom Nicotine Dependence (FTND) IV. Brief WISDM V. Smoking self-efficacy scale Timepoint: Baseline, 3 months and 6 months

Secondary

MeasureTime frame
Depression Anxiety Stress Scale (DASS)Timepoint: Baseline, 3 months and 6 months;Smoking Situation temptation scaleTimepoint: Baseline, 3 months and 6 months;WHOQOL BREFTimepoint: Baseline, 3 months and 6 months

Countries

India

Contacts

Public ContactGautam Sharma

All India Institute of Medical Sciences (AIIMS)

drsharmagautam@gmail.com1126549326

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026